Metagenomic Sequencing Market Size, Trends, Analysis, and Outlook By Products and Services (Reagents and Consumables, Instruments, Sequencing Services, Analysis and Data Interpretation Solutions), By Workflow (Sample Preparation, Sequencing, Data Processing and Analysis), By Technology (16s Rrna Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing and De Novo Assembly, Meta transcriptomics), By Type (Drug Discovery, Clinical Diagnostic, Soil Microbiome, Industrial Applications, Ecological and Environmental, Veterinary, Others), by Country, Segment, and Companies, 2024-2032
The global Metagenomic Sequencing market size is poised to register 15.9% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Metagenomic Sequencing market across By Products and Services (Reagents and Consumables, Instruments, Sequencing Services, Analysis and Data Interpretation Solutions), By Workflow (Sample Preparation, Sequencing, Data Processing and Analysis), By Technology (16s Rrna Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing and De Novo Assembly, Meta transcriptomics), By Type (Drug Discovery, Clinical Diagnostic, Soil Microbiome, Industrial Applications, Ecological and Environmental, Veterinary, Others)
The metagenomic sequencing market is driven by the increasing interest in understanding microbial communities and their role in health and disease, advancements in next-generation sequencing (NGS) technologies and bioinformatics pipelines, and the growing application of metagenomics in environmental monitoring and precision medicine. By 2030, the market is expected to witness significant growth, fueled by expansions in shotgun metagenomics, amplicon sequencing, and single-cell sequencing approaches. Further, expanding applications in microbiome analysis, infectious disease surveillance, and agricultural biotechnology are anticipated to drive market expansion, enabling researchers, clinicians, and biotech companies to explore microbial diversity, uncover novel genes, and develop targeted interventions through metagenomic sequencing services that offer accuracy, scalability, and actionable insights in the metagenomic sequencing market and microbiome research domain.
Metagenomic Sequencing Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Metagenomic Sequencing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Metagenomic Sequencing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Metagenomic Sequencing industry.
Key market trends defining the global Metagenomic Sequencing demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Metagenomic Sequencing Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Metagenomic Sequencing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Metagenomic Sequencing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Metagenomic Sequencing industry
Leading Metagenomic Sequencing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Metagenomic Sequencing companies.
Metagenomic Sequencing Market Study- Strategic Analysis Review
The Metagenomic Sequencing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Metagenomic Sequencing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Metagenomic Sequencing Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Metagenomic Sequencing Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Metagenomic Sequencing market segments. Similarly, Strong market demand is encouraging Canadian Metagenomic Sequencing companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Metagenomic Sequencing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Metagenomic Sequencing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Metagenomic Sequencing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Metagenomic Sequencing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Metagenomic Sequencing Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Metagenomic Sequencing in Asia Pacific. In particular, China, India, and South East Asian Metagenomic Sequencing markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Metagenomic Sequencing Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Metagenomic Sequencing Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Metagenomic Sequencing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Metagenomic Sequencing.
Metagenomic Sequencing Market Company Profiles
The global Metagenomic Sequencing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Azenta Life Sciences Inc, BGI Group, DNASTAR Inc, Eurofins Scientific, Illumina Inc, Integragen SA, Microsynth AG, Novogene Corp Co. Ltd, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc, PerkinElmer Inc, Psomagen Inc, QIAGEN N.V., Tecan Group AG, Thermo Fisher Scientific Inc, Zymo Research Corp.
Recent Metagenomic Sequencing Market Developments
The global Metagenomic Sequencing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Metagenomic Sequencing Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Products and Services
Reagents and Consumables
Instruments
Sequencing Services
Analysis and Data Interpretation Solutions
By Workflow
Sample Preparation
Sequencing
Data Processing and Analysis
By Technology
16s Rrna Sequencing
Shotgun Metagenomic Sequencing
Whole-Genome Sequencing and De Novo Assembly
Meta transcriptomics
By Type
Drug Discovery
Clinical Diagnostic
Soil Microbiome
Industrial Applications
Ecological and Environmental
Veterinary
Others
Geographical Segmentation:
Azenta Life Sciences Inc
BGI Group
DNASTAR Inc
Eurofins Scientific
Illumina Inc
Integragen SA
Microsynth AG
Novogene Corp Co. Ltd
Oxford Nanopore Technologies plc
Pacific Biosciences of California Inc
PerkinElmer Inc
Psomagen Inc
QIAGEN N.V.
Tecan Group AG
Thermo Fisher Scientific Inc
Zymo Research Corp
Formats Available: Excel, PDF, and PPT
The metagenomic sequencing market is driven by the increasing interest in understanding microbial communities and their role in health and disease, advancements in next-generation sequencing (NGS) technologies and bioinformatics pipelines, and the growing application of metagenomics in environmental monitoring and precision medicine. By 2030, the market is expected to witness significant growth, fueled by expansions in shotgun metagenomics, amplicon sequencing, and single-cell sequencing approaches. Further, expanding applications in microbiome analysis, infectious disease surveillance, and agricultural biotechnology are anticipated to drive market expansion, enabling researchers, clinicians, and biotech companies to explore microbial diversity, uncover novel genes, and develop targeted interventions through metagenomic sequencing services that offer accuracy, scalability, and actionable insights in the metagenomic sequencing market and microbiome research domain.
Metagenomic Sequencing Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Metagenomic Sequencing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Metagenomic Sequencing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Metagenomic Sequencing industry.
Key market trends defining the global Metagenomic Sequencing demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Metagenomic Sequencing Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Metagenomic Sequencing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Metagenomic Sequencing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Metagenomic Sequencing industry
Leading Metagenomic Sequencing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Metagenomic Sequencing companies.
Metagenomic Sequencing Market Study- Strategic Analysis Review
The Metagenomic Sequencing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Metagenomic Sequencing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Metagenomic Sequencing Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Metagenomic Sequencing Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Metagenomic Sequencing market segments. Similarly, Strong market demand is encouraging Canadian Metagenomic Sequencing companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Metagenomic Sequencing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Metagenomic Sequencing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Metagenomic Sequencing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Metagenomic Sequencing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Metagenomic Sequencing Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Metagenomic Sequencing in Asia Pacific. In particular, China, India, and South East Asian Metagenomic Sequencing markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Metagenomic Sequencing Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Metagenomic Sequencing Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Metagenomic Sequencing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Metagenomic Sequencing.
Metagenomic Sequencing Market Company Profiles
The global Metagenomic Sequencing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Azenta Life Sciences Inc, BGI Group, DNASTAR Inc, Eurofins Scientific, Illumina Inc, Integragen SA, Microsynth AG, Novogene Corp Co. Ltd, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc, PerkinElmer Inc, Psomagen Inc, QIAGEN N.V., Tecan Group AG, Thermo Fisher Scientific Inc, Zymo Research Corp.
Recent Metagenomic Sequencing Market Developments
The global Metagenomic Sequencing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Metagenomic Sequencing Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Products and Services
Reagents and Consumables
Instruments
Sequencing Services
Analysis and Data Interpretation Solutions
By Workflow
Sample Preparation
Sequencing
Data Processing and Analysis
By Technology
16s Rrna Sequencing
Shotgun Metagenomic Sequencing
Whole-Genome Sequencing and De Novo Assembly
Meta transcriptomics
By Type
Drug Discovery
Clinical Diagnostic
Soil Microbiome
Industrial Applications
Ecological and Environmental
Veterinary
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Azenta Life Sciences Inc
BGI Group
DNASTAR Inc
Eurofins Scientific
Illumina Inc
Integragen SA
Microsynth AG
Novogene Corp Co. Ltd
Oxford Nanopore Technologies plc
Pacific Biosciences of California Inc
PerkinElmer Inc
Psomagen Inc
QIAGEN N.V.
Tecan Group AG
Thermo Fisher Scientific Inc
Zymo Research Corp
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Metagenomic Sequencing Market Overview and Key Findings, 2024
1.2 Metagenomic Sequencing Market Size and Growth Outlook, 2021- 2030
1.3 Metagenomic Sequencing Market Growth Opportunities to 2030
1.4 Key Metagenomic Sequencing Market Trends and Challenges
1.4.1 Metagenomic Sequencing Market Drivers and Trends
1.4.2 Metagenomic Sequencing Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Metagenomic Sequencing Companies
2. METAGENOMIC SEQUENCING MARKET SIZE OUTLOOK TO 2030
2.1 Metagenomic Sequencing Market Size Outlook, USD Million, 2021- 2030
2.2 Metagenomic Sequencing Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. METAGENOMIC SEQUENCING MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. METAGENOMIC SEQUENCING MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Products and Services
Reagents and Consumables
Instruments
Sequencing Services
Analysis and Data Interpretation Solutions
By Workflow
Sample Preparation
Sequencing
Data Processing and Analysis
By Technology
16S RRNA SEQUENCING
Shotgun Metagenomic Sequencing
Whole-Genome Sequencing and De Novo Assembly
Meta transcriptomics
By Type
Drug Discovery
Clinical Diagnostic
Soil Microbiome
Industrial Applications
Ecological and Environmental
Veterinary
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Metagenomic Sequencing Market, 2025
5.2 Asia Pacific Metagenomic Sequencing Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Metagenomic Sequencing Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Metagenomic Sequencing Market, 2025
5.5 Europe Metagenomic Sequencing Market Size Outlook by Type, 2021- 2030
5.6 Europe Metagenomic Sequencing Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Metagenomic Sequencing Market, 2025
5.8 North America Metagenomic Sequencing Market Size Outlook by Type, 2021- 2030
5.9 North America Metagenomic Sequencing Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Metagenomic Sequencing Market, 2025
5.11 South America Pacific Metagenomic Sequencing Market Size Outlook by Type, 2021- 2030
5.12 South America Metagenomic Sequencing Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Metagenomic Sequencing Market, 2025
5.14 Middle East Africa Metagenomic Sequencing Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Metagenomic Sequencing Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Metagenomic Sequencing Market Size Outlook and Revenue Growth Forecasts
6.2 US Metagenomic Sequencing Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Metagenomic Sequencing Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Metagenomic Sequencing Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Metagenomic Sequencing Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Metagenomic Sequencing Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Metagenomic Sequencing Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Metagenomic Sequencing Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Metagenomic Sequencing Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Metagenomic Sequencing Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Metagenomic Sequencing Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Metagenomic Sequencing Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Metagenomic Sequencing Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Metagenomic Sequencing Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Metagenomic Sequencing Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Metagenomic Sequencing Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Metagenomic Sequencing Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Metagenomic Sequencing Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Metagenomic Sequencing Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Metagenomic Sequencing Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Metagenomic Sequencing Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Metagenomic Sequencing Industry Drivers and Opportunities
7. METAGENOMIC SEQUENCING MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. METAGENOMIC SEQUENCING COMPANY PROFILES
8.1 Profiles of Leading Metagenomic Sequencing Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Azenta Life Sciences Inc
BGI Group
DNASTAR Inc
Eurofins Scientific
Illumina Inc
Integragen SA
Microsynth AG
Novogene Corp Co. Ltd
Oxford Nanopore Technologies plc
Pacific Biosciences of California Inc
PerkinElmer Inc
Psomagen Inc
QIAGEN N.V.
Tecan Group AG
Thermo Fisher Scientific Inc
Zymo Research Corp.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Metagenomic Sequencing Market Overview and Key Findings, 2024
1.2 Metagenomic Sequencing Market Size and Growth Outlook, 2021- 2030
1.3 Metagenomic Sequencing Market Growth Opportunities to 2030
1.4 Key Metagenomic Sequencing Market Trends and Challenges
1.4.1 Metagenomic Sequencing Market Drivers and Trends
1.4.2 Metagenomic Sequencing Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Metagenomic Sequencing Companies
2. METAGENOMIC SEQUENCING MARKET SIZE OUTLOOK TO 2030
2.1 Metagenomic Sequencing Market Size Outlook, USD Million, 2021- 2030
2.2 Metagenomic Sequencing Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. METAGENOMIC SEQUENCING MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. METAGENOMIC SEQUENCING MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Products and Services
Reagents and Consumables
Instruments
Sequencing Services
Analysis and Data Interpretation Solutions
By Workflow
Sample Preparation
Sequencing
Data Processing and Analysis
By Technology
16S RRNA SEQUENCING
Shotgun Metagenomic Sequencing
Whole-Genome Sequencing and De Novo Assembly
Meta transcriptomics
By Type
Drug Discovery
Clinical Diagnostic
Soil Microbiome
Industrial Applications
Ecological and Environmental
Veterinary
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Metagenomic Sequencing Market, 2025
5.2 Asia Pacific Metagenomic Sequencing Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Metagenomic Sequencing Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Metagenomic Sequencing Market, 2025
5.5 Europe Metagenomic Sequencing Market Size Outlook by Type, 2021- 2030
5.6 Europe Metagenomic Sequencing Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Metagenomic Sequencing Market, 2025
5.8 North America Metagenomic Sequencing Market Size Outlook by Type, 2021- 2030
5.9 North America Metagenomic Sequencing Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Metagenomic Sequencing Market, 2025
5.11 South America Pacific Metagenomic Sequencing Market Size Outlook by Type, 2021- 2030
5.12 South America Metagenomic Sequencing Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Metagenomic Sequencing Market, 2025
5.14 Middle East Africa Metagenomic Sequencing Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Metagenomic Sequencing Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Metagenomic Sequencing Market Size Outlook and Revenue Growth Forecasts
6.2 US Metagenomic Sequencing Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Metagenomic Sequencing Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Metagenomic Sequencing Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Metagenomic Sequencing Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Metagenomic Sequencing Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Metagenomic Sequencing Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Metagenomic Sequencing Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Metagenomic Sequencing Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Metagenomic Sequencing Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Metagenomic Sequencing Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Metagenomic Sequencing Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Metagenomic Sequencing Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Metagenomic Sequencing Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Metagenomic Sequencing Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Metagenomic Sequencing Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Metagenomic Sequencing Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Metagenomic Sequencing Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Metagenomic Sequencing Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Metagenomic Sequencing Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Metagenomic Sequencing Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Metagenomic Sequencing Industry Drivers and Opportunities
7. METAGENOMIC SEQUENCING MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. METAGENOMIC SEQUENCING COMPANY PROFILES
8.1 Profiles of Leading Metagenomic Sequencing Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Azenta Life Sciences Inc
BGI Group
DNASTAR Inc
Eurofins Scientific
Illumina Inc
Integragen SA
Microsynth AG
Novogene Corp Co. Ltd
Oxford Nanopore Technologies plc
Pacific Biosciences of California Inc
PerkinElmer Inc
Psomagen Inc
QIAGEN N.V.
Tecan Group AG
Thermo Fisher Scientific Inc
Zymo Research Corp.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
